Literature DB >> 17562267

[Quality of life and its influential factors of cancer patients in Shanghai].

Ying Zheng1, Jie-Jun Wang, Jian-Jun Zou, Chun-Xiao Wu, Ping-Ping Bao, Wei Lu.   

Abstract

BACKGROUND &
OBJECTIVE: Now the quality of life of cancer patients has become one of the end-points in cancer researches. It reflects the survival status and prognosis of cancer patients. This study was to determine the quality of life and its influential factors of cancer patients who live in communities in Shanghai, and to design suitable intervention and evaluate the effectiveness of community-based health care service.
METHODS: A total of 7,967 cancer patients who lived in communities in Shanghai were selected through searching Shanghai Cancer Patient Database by cluster sampling. Questionnaire with FACT-G Self-rating Scale was applied; 6,694 valid questionnaires were obtained. The scores of quality of life were calculated and analyzed with multiple linear regression model to determine the influential factors.
RESULTS: The average score of quality of life of the 6 694 cancer patients was 107.62+/-18.77 (95% CI=107.17-108.07). Duration since diagnosis, stage at diagnosis, metastasis status, treatment effect, KPS score, and pain VAS score were main influential factors of quality of life of the cancer patients.
CONCLUSION: Early diagnosis of cancer, improvement of the treatment effect, and providing community health care and analgesic services might improve the quality of life of cancer patients who live in communities.

Entities:  

Mesh:

Year:  2007        PMID: 17562267

Source DB:  PubMed          Journal:  Ai Zheng


  2 in total

1.  Symptoms and quality of life of advanced cancer patients at home: a cross-sectional study in Shanghai, China.

Authors:  Yixin Wang; Jie Shen; Yan Xu
Journal:  Support Care Cancer       Date:  2010-04-28       Impact factor: 3.603

2.  Alerting the illusion of smoking improves quality of life in Chinese male cancer survivors.

Authors:  Juan Xia; Peng Wu; Jiwei Wang; Jinming Yu
Journal:  Cancer Med       Date:  2019-02-08       Impact factor: 4.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.